ITTO20030668A1 - Derivati dell'adamantano dotati di attivita' neuroprotettiva, antidepressiva e anti-ischemica e procedimento per la loro preparazione. - Google Patents

Derivati dell'adamantano dotati di attivita' neuroprotettiva, antidepressiva e anti-ischemica e procedimento per la loro preparazione.

Info

Publication number
ITTO20030668A1
ITTO20030668A1 IT000668A ITTO20030668A ITTO20030668A1 IT TO20030668 A1 ITTO20030668 A1 IT TO20030668A1 IT 000668 A IT000668 A IT 000668A IT TO20030668 A ITTO20030668 A IT TO20030668A IT TO20030668 A1 ITTO20030668 A1 IT TO20030668A1
Authority
IT
Italy
Prior art keywords
antidepressive
adamantan
neuroprotective
derivatives
procedure
Prior art date
Application number
IT000668A
Other languages
English (en)
Inventor
Roberto Artusi
Antonio Giordani
Francesco Makovec
Simona Zanzarola
Original Assignee
Rotta Res Lab S P A O Ra Rottapharm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rotta Res Lab S P A O Ra Rottapharm filed Critical Rotta Res Lab S P A O Ra Rottapharm
Priority to IT000668A priority Critical patent/ITTO20030668A1/it
Priority to ES04020517T priority patent/ES2369888T3/es
Priority to PT04020517T priority patent/PT1512679E/pt
Priority to EP04020517A priority patent/EP1512679B1/en
Priority to AT04020517T priority patent/ATE517079T1/de
Priority to CA002479613A priority patent/CA2479613A1/en
Priority to US10/931,245 priority patent/US7145037B2/en
Priority to AU2004206990A priority patent/AU2004206990A1/en
Priority to JP2004254373A priority patent/JP5116207B2/ja
Publication of ITTO20030668A1 publication Critical patent/ITTO20030668A1/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/30—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to nitro or nitroso groups
    • C07C279/32—N-nitroguanidines
    • C07C279/36—Substituted N-nitroguanidines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C257/00—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines
    • C07C257/10—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines
    • C07C257/14—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines having carbon atoms of amidino groups bound to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/04—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/56—Ring systems containing bridged rings
    • C07C2603/58—Ring systems containing bridged rings containing three rings
    • C07C2603/70—Ring systems containing bridged rings containing three rings containing only six-membered rings
    • C07C2603/74—Adamantanes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
IT000668A 2003-09-02 2003-09-02 Derivati dell'adamantano dotati di attivita' neuroprotettiva, antidepressiva e anti-ischemica e procedimento per la loro preparazione. ITTO20030668A1 (it)

Priority Applications (9)

Application Number Priority Date Filing Date Title
IT000668A ITTO20030668A1 (it) 2003-09-02 2003-09-02 Derivati dell'adamantano dotati di attivita' neuroprotettiva, antidepressiva e anti-ischemica e procedimento per la loro preparazione.
ES04020517T ES2369888T3 (es) 2003-09-02 2004-08-30 Derivados de adamantano novedosos con actividades neuroprotectoras, antidepresivas y antiisquémicas, y procedimiento para preparar los mismos.
PT04020517T PT1512679E (pt) 2003-09-02 2004-08-30 Novos derivados de adamantano com actividades neuroprotectoras, anti-depressivas e anti-isquémicas e processo para os preparar
EP04020517A EP1512679B1 (en) 2003-09-02 2004-08-30 Novel adamantane derivatives with neuroprotective, antidepressant and anti-ischaemic activities, and process for preparing them
AT04020517T ATE517079T1 (de) 2003-09-02 2004-08-30 Adamantanderivate mit neuroprotektoren, antidepressoren und antiischaemischer wirkung, und verfahren zur ihrer herstellung
CA002479613A CA2479613A1 (en) 2003-09-02 2004-08-31 Novel adamantane derivatives with neuroprotective, antidepressant and anti-ischaemic activities, and process for preparing them
US10/931,245 US7145037B2 (en) 2003-09-02 2004-09-01 Adamantane derivatives with neuroprotective, antidepressant and anti-ischaemic activities, and process for preparing them
AU2004206990A AU2004206990A1 (en) 2003-09-02 2004-09-01 Novel adamantane derivatives with neuroprotective, antidepressant and anti-ischaemic activities, and process for preparing them
JP2004254373A JP5116207B2 (ja) 2003-09-02 2004-09-01 神経保護、抗うつおよび抗虚血活性を有する新規アダマンタン誘導体、およびその製造法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT000668A ITTO20030668A1 (it) 2003-09-02 2003-09-02 Derivati dell'adamantano dotati di attivita' neuroprotettiva, antidepressiva e anti-ischemica e procedimento per la loro preparazione.

Publications (1)

Publication Number Publication Date
ITTO20030668A1 true ITTO20030668A1 (it) 2005-03-03

Family

ID=34131246

Family Applications (1)

Application Number Title Priority Date Filing Date
IT000668A ITTO20030668A1 (it) 2003-09-02 2003-09-02 Derivati dell'adamantano dotati di attivita' neuroprotettiva, antidepressiva e anti-ischemica e procedimento per la loro preparazione.

Country Status (9)

Country Link
US (1) US7145037B2 (it)
EP (1) EP1512679B1 (it)
JP (1) JP5116207B2 (it)
AT (1) ATE517079T1 (it)
AU (1) AU2004206990A1 (it)
CA (1) CA2479613A1 (it)
ES (1) ES2369888T3 (it)
IT (1) ITTO20030668A1 (it)
PT (1) PT1512679E (it)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007109292A2 (en) * 2006-03-21 2007-09-27 Wisconsin Alumni Research Foundation Ionizable isotopic labeling reagents for relative quantification by mass spectrometry
US7977511B2 (en) * 2006-04-07 2011-07-12 Ssv Therapeutics, Inc. Carnitine conjugates of adamantanamines and neramexane derivatives as dual prodrugs for various uses
US7893289B2 (en) * 2007-02-21 2011-02-22 Ssv Therapeutics, Inc. Adamantanamines and neramexane salts of thiomolybdic and thiotungstic acids
DE102007022007A1 (de) * 2007-05-08 2008-11-13 Schebo Biotech Ag Neuartike Pharmazeutika, Verfahren zu ihrer Herstellung und ihre Verwendung in der Prophylaxe und Therapie von ZNS-Erkrankungen und Diabetes
WO2010019712A1 (en) * 2008-08-12 2010-02-18 The Trustees Of The University Of Pennsylvania Modulation of influenza virus
US9453005B2 (en) 2008-09-16 2016-09-27 The Trustees Of The University Of Pennsylvania Inhibition of influenza M2 proton channel
US8592216B2 (en) 2009-04-15 2013-11-26 Wisconsin Alumni Research Foundation Labeling peptides with tertiary amines and other basic functional groups for improved mass spectrometric analysis
WO2011022191A1 (en) * 2009-08-21 2011-02-24 The Trustees Of The University Of Pennsylvania Adamantane analogs
US20110065762A1 (en) * 2009-09-11 2011-03-17 Jizhou Wang Methods of use of antiviral compounds
US8440720B2 (en) * 2009-09-11 2013-05-14 Influmedix, Inc. Methods of use of antiviral compounds
JP5562716B2 (ja) * 2010-05-12 2014-07-30 花王株式会社 電位依存性カチオンチャネル抑制剤
US9884832B2 (en) 2011-12-06 2018-02-06 The Trustees Of The University Of Pennsylvania Inhibitors targeting drug-resistant influenza A
JP7543136B2 (ja) * 2017-11-22 2024-09-02 パノラマ リサーチ，インコーポレイティド Ｃｎｓ疾患を治療するためのアミノアダマンチルナイトレート化合物およびそれらの使用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US28836A (en) * 1860-06-26 Improvement in plows
GB1274652A (en) 1968-08-27 1972-05-17 Lilly Industries Ltd Adamantanyl-alkylamine derivatives and their preparation
US4007181A (en) * 1974-02-11 1977-02-08 The Upjohn Company Adamantyl containing guanidines
ES2059602T3 (es) 1989-04-14 1994-11-16 Merz & Co Gmbh & Co Uso de derivados de adamantano para la prevencion y tratamiento de isquemia cerebral.
WO1991018868A1 (en) 1990-05-25 1991-12-12 STATE OF OREGON, acting by and through the OREGON STATE BOARD OF HIGHER EDUCATION, acting for and onbehalf of the OREGON HEALTH SCIENCES UNIVERSITY Substituted guanidines having high binding to the sigma receptor and the use thereof
JP2001520215A (ja) 1997-10-21 2001-10-30 ケンブリッジ・ニューロサイエンス・インコーポレイティッド 薬学的に活性な化合物ならびに利用法
GB9726388D0 (en) * 1997-12-12 1998-02-11 Cerebrus Ltd Chemical compounds
GB9802225D0 (en) * 1998-02-02 1998-04-01 Cerebrus Ltd Chemical compounds
GB9803536D0 (en) 1998-02-19 1998-04-15 Black James Foundation Histamine H,receptor ligands
US6645968B2 (en) 1999-08-03 2003-11-11 Abbott Laboratories Potassium channel openers
ITTO20010110A1 (it) * 2001-02-08 2002-08-08 Rotta Research Lab Nuovi derivati benzamidinici dotati di attivita' anti-infiammatoria ed immunosoppressiva.
US6974869B2 (en) 2001-09-18 2005-12-13 Bristol-Myers Squibb Pharma Company Piperizinones as modulators of chemokine receptor activity

Also Published As

Publication number Publication date
PT1512679E (pt) 2011-08-03
CA2479613A1 (en) 2005-03-02
EP1512679A1 (en) 2005-03-09
ATE517079T1 (de) 2011-08-15
JP5116207B2 (ja) 2013-01-09
EP1512679B1 (en) 2011-07-20
US7145037B2 (en) 2006-12-05
ES2369888T3 (es) 2011-12-07
AU2004206990A1 (en) 2005-03-17
JP2005075832A (ja) 2005-03-24
US20050049312A1 (en) 2005-03-03

Similar Documents

Publication Publication Date Title
CY1111206T1 (el) Βενζοθειοφαινια υποκατεστημενα με πιπεραζινη για την αγωγη διανοητικων διαταραχων
UY27952A1 (es) Nuevos derivados de benzoimidazol útiles como agentes antiproliferativos
UY28135A1 (es) Derivados de pirimidina para el tratamiento de crecimiento celular anormal
UY26086A1 (es) Procedimientos e intermedios para preparar compuestos anticancerosos
SG155180A1 (en) Derivatives of 4-piperazin-1-yl-4-benzo[b]thiophene suitable for the treatment of cns disorders
NO20020305D0 (no) Nye bisyklonukleosidanaloger
MXPA06001274A (es) Compuestos novedosos que poseen actividad inhibitoria contra transporador dependiente de sodio.
CY1117165T1 (el) Καινοφανεις τρικυκλικες ενωσεις
EA200300531A1 (ru) Производные фталазинона
ECSP045483A (es) Derivados de heteroarilamida benzocondensada de tienopiridinas útiles como agentes terapéuticos, composiciones farmacéuticas que incluyen a los mismos, y métodos para su uso
AR038045A1 (es) Agentes terapeuticos
CY1113873T1 (el) Παραγωγα hydroxybenzamide σαν παραγοντες καταστολης της hsp90
TW200716528A (en) Cyclopropanecarboxamide derivatives
PT1512679E (pt) Novos derivados de adamantano com actividades neuroprotectoras, anti-depressivas e anti-isquémicas e processo para os preparar
BR0308145A (pt) Composto, composição farmacêutica, uso de um composto, e, processo para a preparação de um composto
UY27685A1 (es) Indolil-urea derivados de tienopiridinas útiles como agentes antiangiogénicos, y procedimientos para su uso
EP1775289A4 (en) NEW IMIDAZOLIDINE DERIVATIVES
NO20082436L (no) Forbindelser med medisinske effekter grunnet interaksjonen med glukokortikoidreseptor
DE60207796D1 (de) Electrochrome Lösung, enthaltend eine Hydrazonverbindung und mit dieser hergestellte Vorrichtung
BRPI0508768A (pt) derivado de benzopirano da fórmula (i) ou (ii), ou sal farmaceuticamente aceitável do mesmo, medicamento e medicamento para o tratamento de arritmia
ATE302199T1 (de) Quinalozinon-derivate
ES2115855T3 (es) Nuevos derivados de 17-iminometilalquenil-5-beta-14-beta-androstanos y 17-iminoalquil-5-beta,14-beta-androstanos, un procedimiento para su produccion y las composiciones farmaceuticas que los incluyen.
DE60238847D1 (de) Pyrimidinderivate enthaltendes medikament
PL395468A1 (pl) Zwiazki amidoalkilopiperazynylowe do leczenia chorób osrodkowego ukladu nerwowego
ATE257826T1 (de) Benzimidazolderivate und sie enthaltende medikamente